IP Library › Assignment 048168/0558
Patent Assignment
Reel/Frame 048168/0558

Assignment of Assignor's Interest

Recorded: 2019-01-29 Pages: 5
Assignor
ROBINS, HARLAN S.
Executed: 2017-03-06
Assignees
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, SEATTLE, WASHINGTON, 98109
ADAPTIVE BIOTECHNOLOGIES CORPORATION
1551 EASTLAKE AVENUE E, SUITE 200, SEATTLE, WASHINGTON, 98102
Covered Property (1)
High Affinity T Cell Receptors and Uses Thereof
Application: 16/064,161 →
Publication: US 2018/0369280
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License Jul 16, 2018
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046549/0016 →
Assignment of Assignor's Interest Jan 29, 2019
From: SCHMITT, THOMAS M.; GREENBERG, PHILIP D.; CHAPUIS, AUDE G.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 048168/0549 →
Assignment of Assignor's Interest Jan 29, 2019
From: SHERWOOD, ANNA M.
To: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Reel/Frame 048168/0563 →
Merger and Change of Name Jun 9, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060329/0793 →
Merger and Change of Name Aug 4, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060722/0441 →
Security Interest Sep 15, 2022
From: ADAPTIVE BIOTECHNOLOGIES CORPORATION
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 061449/0689 →